C4 Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.41

-0.21 (-8.02%)

As of Mar 29, 10:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +1,528.2% upside

Low Target $29.92

Average Target $39.24

High Target $50.68

Current Price $2.41

Current
$2.41

Target
$39.24

$29.92 $39.24 avg $50.68

Scenario Analysis

Bear Case

$29.92

1,141.5%

Low target

Base Case

$39.24

+1,528.2%

Avg target

Bull Case

$50.68

+2,002.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$3.82

-36.9% from high

52-Week Low

$1.09

+122.1% from low

Target vs 52W High

$39.24

+927.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%